NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Tuesday that its third quarter revenues grew 8 percent year over year, thanks largely to 9 percent growth for its Diagnostics and Genomics group.

For the three months ended July 31, the life sciences company said total revenues rose to $1.20 billion from $1.11 billion in Q3 2017, in line with analysts' average estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.